Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial
- Jiayu Wang
- Quchang Ouyang
- Weimin Xie
- Zhaofeng Niu
- Qingyuan Zhang
- Xi Yan
- Yue’e Teng
- Jianying Chang
- Ying Cheng
- Airong Wang
- Jingfen Wang
- Herui Yao
- Zhuangqing Yang
- Tao Sun
- Zhongsheng Tong
- Xinhong Wu
- Yongsheng Wang
- Enxiang Zhou
- Xiangshun Kong
- Xujuan Wang
- De Zeng
- Shanshan Gu
- Yanyan Hou
- Dandan Gao
- Zerui Qu
- Chenran Han
- Jianmin Fang
- Binghe Xu
2026-08-26